Skip to main content
Erschienen in: AIDS and Behavior 2/2019

14.07.2018 | Original Paper

Timing and Predictors of Initiation on Antiretroviral Therapy Among Newly-Diagnosed HIV-Infected Persons in South Africa

verfasst von: Anna Larsen, Mireille Cheyip, Abraham Tesfay, Peter Vranken, Henry Fomundam, Anthony Wutoh, Getahun Aynalem

Erschienen in: AIDS and Behavior | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Despite a decade of advancing HIV/AIDS treatment policy in South Africa, 20% of people living with HIV (PLHIV) eligible for antiretroviral treatment (ART) remain untreated. To inform universal test and treat (UTT) implementation in South Africa, this analysis describes the rate, timeliness and determinants of ART initiation among newly diagnosed PLHIV. This analysis used routine data from 35 purposively selected primary clinics in three high HIV-burden districts of South Africa from June 1, 2014 to March 31, 2015. Kaplan–Meier survival curves estimated the rate of ART initiation. We identified predictors of ART initiation rate and timely initiation (within 14 days of eligibility determination) using Cox proportional hazards and multivariable logistic regression models in Stata 14.1. Based on national guidelines, 6826 patients were eligible for ART initiation. Under half of men and non-pregnant women were initiated on ART within 14 days (men: 39.7.0%, 95% CI 37.7–41.9; women: 39.9%, 95% CI 38.1–41.7). Pregnant women initiated at a faster rate (within 14 days: 87.6%, 86.1–89.0). ART initiation and timeliness varied significantly by district, facility location, and age, with little to no variation by World Health Organization stage, or CD4 count. Men and non-pregnant women newly diagnosed with HIV who are eligible for ART in South Africa show suboptimal timeliness of ART initiation. If treatment initiation performance is not improved, UTT implementation will be challenging among men and non-pregnant women. UTT programming should be tailored to district and location categories to address contextual differences influencing treatment initiation.
Literatur
2.
Zurück zum Zitat SANAC. South African Global AIDS Response Progress Report. Pretoria, South Africa; 2015. SANAC. South African Global AIDS Response Progress Report. Pretoria, South Africa; 2015.
4.
Zurück zum Zitat Shisana O, Rehle T, Simbayi LC, Zuma K, Jooste S, Zungu N, Labadarios D, Onoya DEA. South African National HIV prevalence, incidence and behaviour survey, 2012. Cape Town: HSRC Press; 2014. p. 194. Shisana O, Rehle T, Simbayi LC, Zuma K, Jooste S, Zungu N, Labadarios D, Onoya DEA. South African National HIV prevalence, incidence and behaviour survey, 2012. Cape Town: HSRC Press; 2014. p. 194.
8.
Zurück zum Zitat The National Department of Health. National Consolidated Guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults. 2015. The National Department of Health. National Consolidated Guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults. 2015.
12.
Zurück zum Zitat van der Hoeven M, Kruger A, Greeff M. Differences in health care seeking behaviour between rural and urban communities in South Africa. Int J Equity Health. 2012;11:31.CrossRefPubMedPubMedCentral van der Hoeven M, Kruger A, Greeff M. Differences in health care seeking behaviour between rural and urban communities in South Africa. Int J Equity Health. 2012;11:31.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Musoke D, Boynton P, Butler C, Musoke MB. Health seeking behaviour and challenges in utilising health facilities in Wakiso district, Uganda. Afr Health Sci. 2014;14:1046–55.CrossRefPubMedPubMedCentral Musoke D, Boynton P, Butler C, Musoke MB. Health seeking behaviour and challenges in utilising health facilities in Wakiso district, Uganda. Afr Health Sci. 2014;14:1046–55.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Aliyu MH, Blevins M, Parrish DD, Megazzini KM, Gebi UI, Muhammad MY, et al. Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria. J Acquir Immune Defic Syndr. 2014;65:e41–9.CrossRefPubMedPubMedCentral Aliyu MH, Blevins M, Parrish DD, Megazzini KM, Gebi UI, Muhammad MY, et al. Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria. J Acquir Immune Defic Syndr. 2014;65:e41–9.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Lahuerta M, Ue F, Hoffman S, Elul B, Kulkarni SG, Wu Y, et al. The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon? J Health Care Poor Underserved. 2013;24:359–83.CrossRefPubMedPubMedCentral Lahuerta M, Ue F, Hoffman S, Elul B, Kulkarni SG, Wu Y, et al. The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon? J Health Care Poor Underserved. 2013;24:359–83.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Fatukasi TV, Cole SR, Moore RD, Mathews WC, Edwards JK, Eron JJ, et al. Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients. PLoS ONE. 2017;12:e0180843.CrossRefPubMedPubMedCentral Fatukasi TV, Cole SR, Moore RD, Mathews WC, Edwards JK, Eron JJ, et al. Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients. PLoS ONE. 2017;12:e0180843.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Mujugira A, Celum C, Thomas KK, Farquhar C, Mugo N, Katabira E, et al. Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships. J Acquir Immune Defic Syndr. 2014;66:436–42.CrossRefPubMedPubMedCentral Mujugira A, Celum C, Thomas KK, Farquhar C, Mugo N, Katabira E, et al. Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships. J Acquir Immune Defic Syndr. 2014;66:436–42.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Ogoina D, Finomo F, Harry T, Inatimi O, Ebuenyi I, Tariladei W, et al. Factors associated with timing of initiation of antiretroviral therapy among HIV-1 infected adults in the Niger Delta Region of Nigeria. PLoS ONE. 2015;10:e0125665.CrossRefPubMedPubMedCentral Ogoina D, Finomo F, Harry T, Inatimi O, Ebuenyi I, Tariladei W, et al. Factors associated with timing of initiation of antiretroviral therapy among HIV-1 infected adults in the Niger Delta Region of Nigeria. PLoS ONE. 2015;10:e0125665.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Abera Abaerei A, Ncayiyana J, Levin J. Health-care utilization and associated factors in Gauteng province, South Africa. Glob Health Action. 2017;10:1305765.CrossRefPubMedPubMedCentral Abera Abaerei A, Ncayiyana J, Levin J. Health-care utilization and associated factors in Gauteng province, South Africa. Glob Health Action. 2017;10:1305765.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Teasdale CA, Wang C, Francois U, Ndahimana JDA, Vincent M, Sahabo R, et al. Time to initiation of antiretroviral therapy among patients who Are ART eligible in Rwanda: improvement over time. J Acquir Immune Defic Syndr. 2015;68:314–21.CrossRefPubMedPubMedCentral Teasdale CA, Wang C, Francois U, Ndahimana JDA, Vincent M, Sahabo R, et al. Time to initiation of antiretroviral therapy among patients who Are ART eligible in Rwanda: improvement over time. J Acquir Immune Defic Syndr. 2015;68:314–21.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Odeny TA, DeCenso B, Dansereau E, Gasasira A, Kisia C, Njuguna P, et al. The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya. J Int AIDS Soc. 2015;18:20019.CrossRefPubMedPubMedCentral Odeny TA, DeCenso B, Dansereau E, Gasasira A, Kisia C, Njuguna P, et al. The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya. J Int AIDS Soc. 2015;18:20019.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Kayigamba FR, Bakker MI, Fikse H, Mugisha V, Asiimwe A, Schim van der Loeff MF. Patient enrolment into HIV care and treatment within 90 days of HIV diagnosis in eight Rwandan health facilities: a review of facility-based registers. PLoS ONE. 2012;7:e36792.CrossRefPubMedPubMedCentral Kayigamba FR, Bakker MI, Fikse H, Mugisha V, Asiimwe A, Schim van der Loeff MF. Patient enrolment into HIV care and treatment within 90 days of HIV diagnosis in eight Rwandan health facilities: a review of facility-based registers. PLoS ONE. 2012;7:e36792.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Murphy RA, Sunpath H, Taha B, Kappagoda S, Maphasa KTM, Kuritzkes DR, et al. Low uptake of antiretroviral therapy after admission with human immunodeficiency virus and tuberculosis in KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis. 2010;14:903–8.PubMedPubMedCentral Murphy RA, Sunpath H, Taha B, Kappagoda S, Maphasa KTM, Kuritzkes DR, et al. Low uptake of antiretroviral therapy after admission with human immunodeficiency virus and tuberculosis in KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis. 2010;14:903–8.PubMedPubMedCentral
25.
Zurück zum Zitat MacLeod W, Fraser N, Shubber Z, Carmona S, Pillay Y, Gorgens M. Analysis of age-and sex-specific HIV care cascades in South Africa suggests unequal progress towards UNAIDS 90-90-90 targets. In: 21st International AIDS Conference Durban. 2016. MacLeod W, Fraser N, Shubber Z, Carmona S, Pillay Y, Gorgens M. Analysis of age-and sex-specific HIV care cascades in South Africa suggests unequal progress towards UNAIDS 90-90-90 targets. In: 21st International AIDS Conference Durban. 2016.
26.
Zurück zum Zitat Grobler A, Kharsany A, Cawood C, Khanyile D, Puren A, Madurai L. Achieving UNAIDS 90-90-90 targets in a high HIV burden district in Kwazulu-Natal, South Africa. Durban: Int AIDS Conf; 2016. Grobler A, Kharsany A, Cawood C, Khanyile D, Puren A, Madurai L. Achieving UNAIDS 90-90-90 targets in a high HIV burden district in Kwazulu-Natal, South Africa. Durban: Int AIDS Conf; 2016.
27.
Zurück zum Zitat Kranzer K, Govindasamy D, Ford N, Johnston V, Lawn SD. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2012;15:17383.CrossRefPubMedPubMedCentral Kranzer K, Govindasamy D, Ford N, Johnston V, Lawn SD. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2012;15:17383.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat McLaren Z, Brouwer E, Ederer D, Fischer K, Branson N. Gender patterns of tuberculosis testing and disease in South Africa. Int J Tuberc Lung Dis. 2015;19:104–10.CrossRefPubMed McLaren Z, Brouwer E, Ederer D, Fischer K, Branson N. Gender patterns of tuberculosis testing and disease in South Africa. Int J Tuberc Lung Dis. 2015;19:104–10.CrossRefPubMed
30.
Zurück zum Zitat Takarinda KC, Harries AD, Mutasa-Apollo T. Critical considerations for adopting the HIV “treat all” approach in Zimbabwe: is the nation poised? Public Heal Action. 2016;6:3–7.CrossRef Takarinda KC, Harries AD, Mutasa-Apollo T. Critical considerations for adopting the HIV “treat all” approach in Zimbabwe: is the nation poised? Public Heal Action. 2016;6:3–7.CrossRef
31.
Zurück zum Zitat Nakanyala T, Patel S, Sawadogo S, Maher A, Banda K, Wolkon A, et al. How close to 90-90-90? Measuring undiagnosed HIV infection, ART use and viral suppression in a community-based sample from Namibia’s highest prevalence region. In: 21st International AIDS Conference Durban. 2016;. Nakanyala T, Patel S, Sawadogo S, Maher A, Banda K, Wolkon A, et al. How close to 90-90-90? Measuring undiagnosed HIV infection, ART use and viral suppression in a community-based sample from Namibia’s highest prevalence region. In: 21st International AIDS Conference Durban. 2016;.
32.
Zurück zum Zitat Kranzer K, Zeinecker J, Ginsberg P, Orrell C, Kalawe NN, Lawn SD, et al. Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS ONE. 2010;5:e13801.CrossRefPubMedPubMedCentral Kranzer K, Zeinecker J, Ginsberg P, Orrell C, Kalawe NN, Lawn SD, et al. Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS ONE. 2010;5:e13801.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat De Schacht C, Lucas C, Mboa C, Gill M, Macasse E, Dimande SA, et al. Access to HIV prevention and care for HIV-exposed and HIV-infected children: a qualitative study in rural and urban Mozambique. BMC Public Health. 2014;14:1240.CrossRefPubMedPubMedCentral De Schacht C, Lucas C, Mboa C, Gill M, Macasse E, Dimande SA, et al. Access to HIV prevention and care for HIV-exposed and HIV-infected children: a qualitative study in rural and urban Mozambique. BMC Public Health. 2014;14:1240.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Mrisho M, Schellenberg JA, Mushi AK, Obrist B, Mshinda H, Tanner M, et al. Factors affecting home delivery in rural Tanzania. Trop Med Int Heal. 2007;12:862–72.CrossRef Mrisho M, Schellenberg JA, Mushi AK, Obrist B, Mshinda H, Tanner M, et al. Factors affecting home delivery in rural Tanzania. Trop Med Int Heal. 2007;12:862–72.CrossRef
35.
Zurück zum Zitat Auld AF, Shiraishi RW, Mbofana F, Couto A, Fetogang EB, El-Halabi S, et al. Lower levels of antiretroviral therapy enrollment among men with HIV compared with women—12 countries, 2002–2013. Morb Mortal Wkly Rep. 2015;64:1281–6.CrossRef Auld AF, Shiraishi RW, Mbofana F, Couto A, Fetogang EB, El-Halabi S, et al. Lower levels of antiretroviral therapy enrollment among men with HIV compared with women—12 countries, 2002–2013. Morb Mortal Wkly Rep. 2015;64:1281–6.CrossRef
38.
Zurück zum Zitat Mugglin C, Estill J, Wandeler G, Bender N, Egger M, Gsponer T, et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health. 2012;17:1509–20.CrossRefPubMedPubMedCentral Mugglin C, Estill J, Wandeler G, Bender N, Egger M, Gsponer T, et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health. 2012;17:1509–20.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Chimbwandira F, Mhango E, Makombe S, Midiani D, Houston J. Impact of an innovative approach to prevent mother-to-child transmission of HIV-Malawi. Morb Mortal Wkly Rep. 2013;62:148–51. Chimbwandira F, Mhango E, Makombe S, Midiani D, Houston J. Impact of an innovative approach to prevent mother-to-child transmission of HIV-Malawi. Morb Mortal Wkly Rep. 2013;62:148–51.
40.
Zurück zum Zitat Dellar RC, Dlamini S, Karim QA. Adolescent girls and young women: key populations for HIV epidemic control. J Int AIDS Soc. 2015;18:64–70.CrossRef Dellar RC, Dlamini S, Karim QA. Adolescent girls and young women: key populations for HIV epidemic control. J Int AIDS Soc. 2015;18:64–70.CrossRef
41.
Zurück zum Zitat Massyn N, Peer N, Padarath A, Barron P, Day C. District health barometer. Pretoria: Health Systems Trust; 2015. Massyn N, Peer N, Padarath A, Barron P, Day C. District health barometer. Pretoria: Health Systems Trust; 2015.
42.
Zurück zum Zitat Abay SM, Deribe K, Reda AA, Biadgilign S, Datiko D, Assefa T, et al. The effect of early initiation of antiretroviral therapy in TB/HIV-coinfected patients: a systematic review and meta-analysis. J Int Assoc Provid AIDS Care. 2015;14:560–70.CrossRefPubMed Abay SM, Deribe K, Reda AA, Biadgilign S, Datiko D, Assefa T, et al. The effect of early initiation of antiretroviral therapy in TB/HIV-coinfected patients: a systematic review and meta-analysis. J Int Assoc Provid AIDS Care. 2015;14:560–70.CrossRefPubMed
Metadaten
Titel
Timing and Predictors of Initiation on Antiretroviral Therapy Among Newly-Diagnosed HIV-Infected Persons in South Africa
verfasst von
Anna Larsen
Mireille Cheyip
Abraham Tesfay
Peter Vranken
Henry Fomundam
Anthony Wutoh
Getahun Aynalem
Publikationsdatum
14.07.2018
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 2/2019
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-018-2222-2

Weitere Artikel der Ausgabe 2/2019

AIDS and Behavior 2/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.